Targeting cPLA2 derived lipid hydroperoxides as a potential intervention for sarcopenia

[1]  Marco Piñón,et al.  I Overview , 2020, The Diaries and Letters of Lord Woolton 1940-1945.

[2]  Caroline S. Kinter,et al.  Molecular changes in transcription and metabolic pathways underlying muscle atrophy in the CuZnSOD null mouse model of sarcopenia , 2020, GeroScience.

[3]  Kevin W. Eliceiri,et al.  ImageJ for the Next Generation of Scientific Image Data , 2019, Microscopy and Microanalysis.

[4]  Caroline S. Kinter,et al.  Metabolic and Stress Response Changes Precede Disease Onset in the Spinal Cord of Mutant SOD1 ALS Mice , 2019, Front. Neurosci..

[5]  Ronald J. Moore,et al.  Improving mitochondrial function with SS-31 reverses age-related redox stress and improves exercise tolerance in aged mice. , 2019, Free radical biology & medicine.

[6]  G. Rao,et al.  Emerging role of 12/15-Lipoxygenase (ALOX15) in human pathologies. , 2019, Progress in lipid research.

[7]  T. Kiss,et al.  Nrf2 deficiency exacerbates age-related contractile dysfunction and loss of skeletal muscle mass , 2018, Redox biology.

[8]  E. A. Hafez,et al.  Synopsis of arachidonic acid metabolism: A review , 2018, Journal of advanced research.

[9]  L. V. van Loon,et al.  Age-Associated Impairments in Mitochondrial ADP Sensitivity Contribute to Redox Stress in Senescent Human Skeletal Muscle. , 2018, Cell reports.

[10]  M. Jackson,et al.  Denervated muscle fibers induce mitochondrial peroxide generation in neighboring innervated fibers: Role in muscle aging , 2017, Free radical biology & medicine.

[11]  Scott M. Ebert,et al.  Role of ATF4 in skeletal muscle atrophy , 2017, Current opinion in clinical nutrition and metabolic care.

[12]  M. Conrad,et al.  On the Mechanism of Cytoprotection by Ferrostatin-1 and Liproxstatin-1 and the Role of Lipid Peroxidation in Ferroptotic Cell Death , 2017, ACS central science.

[13]  Kevin W. Eliceiri,et al.  ImageJ2: ImageJ for the next generation of scientific image data , 2017, BMC Bioinformatics.

[14]  G. Gouspillou,et al.  Denervation drives mitochondrial dysfunction in skeletal muscle of octogenarians , 2016, The Journal of physiology.

[15]  R. Levy,et al.  Reduction of cytosolic phospholipase A2α upregulation delays the onset of symptoms in SOD1G93A mouse model of amyotrophic lateral sclerosis , 2016, Journal of Neuroinflammation.

[16]  J. Brown,et al.  Diet‐induced obesity alters anabolic signalling in mice at the onset of skeletal muscle regeneration , 2015, Acta physiologica.

[17]  Jaak Vilo,et al.  ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap , 2015, Nucleic Acids Res..

[18]  K. Sataranatarajan,et al.  Neuron specific reduction in CuZnSOD is not sufficient to initiate a full sarcopenia phenotype , 2015, Redox biology.

[19]  Wenjun Xie,et al.  Genetically enhancing mitochondrial antioxidant activity improves muscle function in aging , 2014, Proceedings of the National Academy of Sciences.

[20]  J. Bonventre,et al.  Cytosolic Phospholipase A2 Protein as a Novel Therapeutic Target for Spinal Cord Injury , 2014, Annals of neurology.

[21]  Yun Shi,et al.  Neuron‐specific expression of CuZnSOD prevents the loss of muscle mass and function that occurs in homozygous CuZnSOD‐knockout mice , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  H. Szeto.  First‐in‐class cardiolipin‐protective compound as a therapeutic agent to restore mitochondrial bioenergetics , 2014, British journal of pharmacology.

[23]  Yiqiang Zhang,et al.  Genetic ablation of 12/15-lipoxygenase but not 5-lipoxygenase protects against denervation-induced muscle atrophy. , 2014, Free radical biology & medicine.

[24]  Michael P. Siegel,et al.  Mitochondrial‐targeted peptide rapidly improves mitochondrial energetics and skeletal muscle performance in aged mice , 2013, Aging cell.

[25]  Yun Shi,et al.  CuZnSOD gene deletion targeted to skeletal muscle leads to loss of contractile force but does not cause muscle atrophy in adult mice , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  C. Cooper,et al.  Quality of Life in Sarcopenia and Frailty , 2013, Calcified Tissue International.

[27]  Michael Kinter,et al.  A Quantitative Proteomic Profile of the Nrf2-Mediated Antioxidant Response of Macrophages to Oxidized LDL Determined by Multiplexed Selected Reaction Monitoring , 2012, PloS one.

[28]  F. Muller,et al.  Dietary restriction attenuates age‐associated muscle atrophy by lowering oxidative stress in mice even in complete absence of CuZnSOD , 2012, Aging cell.

[29]  A. Landar,et al.  Cell signalling by reactive lipid species: new concepts and molecular mechanisms , 2012, The Biochemical journal.

[30]  Sharon L. Rowan,et al.  Denervation Causes Fiber Atrophy and Myosin Heavy Chain Co-Expression in Senescent Skeletal Muscle , 2012, PloS one.

[31]  T. Prolla,et al.  Mitochondrial Oxidative Stress Mediates Angiotensin II–Induced Cardiac Hypertrophy and G&agr;q Overexpression–Induced Heart Failure , 2011, Circulation research.

[32]  Eoin Fahy,et al.  Lipidomics reveals a remarkable diversity of lipids in human plasma1[S] , 2010, Journal of Lipid Research.

[33]  C. Glass,et al.  Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. , 2010, Molecular cell.

[34]  F. Muller,et al.  Increased superoxide in vivo accelerates age‐associated muscle atrophy through mitochondrial dysfunction and neuromuscular junction degeneration , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  Brendan MacLean,et al.  Bioinformatics Applications Note Gene Expression Skyline: an Open Source Document Editor for Creating and Analyzing Targeted Proteomics Experiments , 2022 .

[36]  F. Muller,et al.  Denervation Induces Cytosolic Phospholipase A2-mediated Fatty Acid Hydroperoxide Generation by Muscle Mitochondria* , 2009, Journal of Biological Chemistry.

[37]  A. Salmon,et al.  Reduction of mitochondrial H2O2 by overexpressing peroxiredoxin 3 improves glucose tolerance in mice , 2008, Aging cell.

[38]  C. Ufer,et al.  Molecular biology of glutathione peroxidase 4: from genomic structure to developmental expression and neural function , 2007, Biological chemistry.

[39]  F. Muller,et al.  Denervation-induced skeletal muscle atrophy is associated with increased mitochondrial ROS production. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.

[40]  H. Szeto.  Mitochondria-targeted peptide antioxidants: Novel neuroprotective agents , 2006, The AAPS Journal.

[41]  L. Horrocks,et al.  Inhibitors of Brain Phospholipase A2 Activity: Their Neuropharmacological Effects and Therapeutic Importance for the Treatment of Neurologic Disorders , 2006, Pharmacological Reviews.

[42]  H. Szeto.  Cell-permeable, mitochondrial-targeted, peptide antioxidants , 2006, The AAPS Journal.

[43]  M. Emond,et al.  Extension of Murine Life Span by Overexpression of Catalase Targeted to Mitochondria , 2005, Science.

[44]  M. Beal,et al.  Integrative role of cPLA2 with COX‐2 and the effect of non‐steriodal anti‐inflammatory drugs in a transgenic mouse model of amyotrophic lateral sclerosis , 2005, Journal of neurochemistry.

[45]  J. Morrow,et al.  F2-Isoprostanes as markers of oxidative stress in vivo: An overview , 2005, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[46]  Guoyao Wu,et al.  Glutathione metabolism and its implications for health. , 2004, The Journal of nutrition.

[47]  Ronenn Roubenoff,et al.  The Healthcare Costs of Sarcopenia in the United States , 2004, Journal of the American Geriatrics Society.

[48]  R. Liao,et al.  Deletion of cytosolic phospholipase A2 promotes striated muscle growth , 2003, Nature Medicine.

[49]  O. Delbono.  Neural control of aging skeletal muscle , 2003, Aging cell.

[50]  P. Cohen,et al.  Serine 727 Phosphorylation and Activation of Cytosolic Phospholipase A2 by MNK1-related Protein Kinases* , 2000, The Journal of Biological Chemistry.

[51]  J. Morrow,et al.  Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. , 2000, Free radical biology & medicine.

[52]  C. Epstein,et al.  Superoxide-mediated cytotoxicity in superoxide dismutase-deficient fetal fibroblasts. , 1997, Archives of biochemistry and biophysics.

[53]  S. Okuda,et al.  Arachidonic acid as a neurotoxic and neurotrophic substance , 1995, Progress in Neurobiology.

[54]  M. Gelb,et al.  Slow- and tight-binding inhibitors of the 85-kDa human phospholipase A2. , 1993, Biochemistry.

[55]  B. Mosinger,et al.  Targeted oncogene activation by site-specific recombination in transgenic mice. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[56]  J. Faulkner,et al.  Contractile properties of skeletal muscles from young, adult and aged mice. , 1988, The Journal of physiology.

[57]  A. McComas,et al.  Physiological changes in ageing muscles , 1973, Journal of neurology, neurosurgery, and psychiatry.

[58]  H. Woodrow,et al.  : A Review of the , 2018 .

[59]  N. Wolf.  Comparative Biology of Aging , 2010 .

[60]  D J Barker,et al.  Muscle strength, activity, housing and the risk of falls in elderly people. , 1989, Age and ageing.

[61]  William B. Jakoby,et al.  Enzymatic basis of detoxication , 1980 .